These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32951438)

  • 1. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia.
    Schneider KE; White RH; O'Rourke A; Kilkenny ME; Perdue M; Sherman SG; Grieb SM; Allen ST
    AIDS Care; 2021 Jun; 33(6):721-728. PubMed ID: 32951438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.
    Allen ST; O'Rourke A; White RH; Smith KC; Weir B; Lucas GM; Sherman SG; Grieb SM
    AIDS Behav; 2020 Jun; 24(6):1942-1950. PubMed ID: 31853771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.
    Schneider KE; White RH; Musci RJ; O'Rourke A; Kilkenny ME; Sherman SG; Allen ST
    J Stud Alcohol Drugs; 2020 Nov; 81(6):740-749. PubMed ID: 33308403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
    Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
    Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.
    Carter G; Meyerson B; Rivers P; Crosby R; Lawrence C; Cope SD; DeBruicker D; Levin S; Meeks W; Thomas C; Turner B; Abert C; Coles H; Allen A; Gonzalez-Fagoaga E; Grivois-Shah R
    AIDS Behav; 2021 Oct; 25(10):3085-3096. PubMed ID: 34003385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.
    Mistler CB; Copenhaver MM; Shrestha R
    AIDS Behav; 2021 May; 25(5):1490-1506. PubMed ID: 32749627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study.
    Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):449-452. PubMed ID: 36150038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting Injectable PrEP Interest and General PrEP Awareness among People who Inject Drugs in the San Diego-Tijuana Border Metroplex.
    Eger WH; Bazzi AR; Valasek CJ; Vera CF; Harvey-Vera A; Artamonova I; Rangel MG; Strathdee SA; Pines HA
    AIDS Behav; 2024 May; 28(5):1650-1661. PubMed ID: 38319461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
    Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
    PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
    AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.
    Sherman SG; Schneider KE; Park JN; Allen ST; Hunt D; Chaulk CP; Weir BW
    Drug Alcohol Depend; 2019 Feb; 195():148-155. PubMed ID: 30639794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider Implicit Bias in Prescribing HIV Pre-exposure Prophylaxis (PrEP) to People Who Inject Drugs.
    Dubov A; Krakower DS; Rockwood N; Montgomery S; Shoptaw S
    J Gen Intern Med; 2023 Oct; 38(13):2928-2935. PubMed ID: 36964426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness and Correlates of HIV Pre-Exposure Prophylaxis (PrEP) Among HIV-negative People Who Access Syringe Services in Seattle, Washington.
    Corcorran MA; Scott JD; Tinsley J; Wald A; Glick SN
    Subst Use Misuse; 2022; 57(3):337-343. PubMed ID: 34895022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
    Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
    Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
    Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
    Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.
    King AR; Shah S; Randall LA; Frew PM; Spaulding A; ; Holloway IW
    BMC Infect Dis; 2022 Sep; 22(1):737. PubMed ID: 36104676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California.
    Bazzi AR; Valasek CJ; Streuli SA; Vera CF; Harvey-Vera A; Philbin MM; Biello KB; Roth AM; Strathdee SA; Pines HA
    AIDS Patient Care STDS; 2022 Jul; 36(7):254-262. PubMed ID: 35727647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019.
    Furukawa NW; Weimer M; Willenburg KS; Kilkenny ME; Atkins AD; Paul McClung R; Hansen Z; Napier K; Handanagic S; Carnes NA; Kemp Rinderle J; Neblett-Fanfair R; Oster AM; Smith DK
    Public Health Rep; 2022; 137(1):25-31. PubMed ID: 33646890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
    Pleuhs B; Mistler CB; Quinn KG; Dickson-Gomez J; Walsh JL; Petroll AE; John SA
    J Prim Care Community Health; 2022; 13():21501319211063999. PubMed ID: 35068243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
    Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
    AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.